Human leptospirosis: Management and prognosis
First Department of Internal Medicine, School of Medicine, Ehime University, Ehime 791-0295, Japan
First Department of Internal Medicine, School of Medicine, Ehime University, Ehime 791-0295
As leptospirosis is a treatable disease, early diagnosis and prompt treatment are important for better prognosis. Early diagnosis depends on the knowledge of epidemiological factors, presenting features and use of appropriate laboratory tests. Early institution of appropriate antimicrobial therapy in combination with supportive therapy reduces the mortality from this disease. Leptospires are sensitive to a variety of antimicrobial agents, including penicillin, cephems, aminoglycosides, tetracyclines and macrolides. Of these antimicrobial agents, short-term treatment with streptomycin exterminates, leptospires. When penicillin, cephems, tetracylines and macrolides are used, long-term therapy with large doses may be required from the early stage of the disease until the appearance of antibodies.
|How to cite this article:|
Kobayashi Y. Human leptospirosis: Management and prognosis.J Postgrad Med 2005;51:201-204
|How to cite this URL:|
Kobayashi Y. Human leptospirosis: Management and prognosis. J Postgrad Med [serial online] 2005 [cited 2022 Aug 19 ];51:201-204
Available from: https://www.jpgmonline.com/text.asp?2005/51/3/201/19021
Human leptospirosis, an acute febrile illness that presents with a wide variety of clinical manifestations, is encountered throughout the world, especially in tropical and subtropical areas with high rainfall. ,,,,,,The epidemics tend to follow natural disasters such as cyclones and floods. ,,,,,,,,,,,,,,, Leptospirosis is a treatable disease, and hence early diagnosis and prompt treatment are important for the improvement of prognosis. Although, efforts to reach a definitive diagnosis should always be undertaken, prompt institution of pertinent therapy should take precedence, as patients with leptospirosis are known to demonstrate a rapid deterioration in their clinical course. This is especially so as the serological tests do not yield a positive result for about a week after the onset of illness, and cultures may not become positive for several weeks. Under such circumstances, therapy could be initiated on the basis of clinical manifestations under appropriate epidemiological situations.
Collecting evidence for diagnosing leptospirosis
In the medical examination, medical professionals must always keep leptospirosis in mind to allow for early suitable treatment. The clinical manifestations of leptospirosis are variable, ranging from mild febrile illness to icteric-haemorrhagic illness with dysfunction of several organ-systems. The diagnosis is suspected on the basis of a combination of evidences generated by clinical manifestations, laboratory findings, clinical course and above all, epidemiological features (location, season, habits, occupation, contact with animals, travel to endemic areas, leisure activities, etc.). The most characteristic clinical signs for early diagnosis are acute febrile illness of sudden onset, severe general malaise, lumbago, muscular pains and conjunctival suffusion. Proteinuria, raised erythrocyte sedimentation rate, and leucocytosis with neutrophilia are the most indicative clinical laboratory findings for early diagnosis., Serum aspartate aminotransferase (AST/SGOT), alanine aminotransferase (ALT/SGPT) and lactic dehydrogenase (LDH) levels are slightly elevated even in severe patients with jaundice. These findings are very important in differentiating between leptospirosis and viral hepatitis. Although, jaundice and haemorrhage are the most important signs of the severe form of leptospirosis, they are rarely useful in early diagnosis.
Appropriate chemotherapy and supportive therapy help reduce the mortality of severe cases. Early treatment is very important. If the disease is not treated appropriately within the first 2-3 days, it may progress in severity. In the olden days, immune horse serum or specific immunoglobulin were used, and proved to be effective when given early., However, availability of effective antimicrobial therapy has supplanted the use of these remedies. Effective antimicrobial therapy should also be initiated before the fifth day after the onset of illness.
General management and supportive therapy
General management of leptospirosis includes providing symptomatic and supportive therapy, as indicated by the nature and severity of the symptoms and signs. Bed rest is required for 1-2 weeks in the mild forms, and for 2-4 weeks in the severe forms. Return to work should be gradual. The progress is monitored with routine measurement of temperature, pulse rate and blood pressure, monitoring of the urinary output and fluid balance, and review of tests such as complete blood count, erythrocyte sedimentation rate, liver function tests, urinalysis, blood urea nitrogen (BUN), creatinine and electrolyte analysis.
Chest radiograph, electrocardiogram, determination of bleeding, clotting and prothrombin time, and analysis of cerebrospinal fluid are also important and are done to determine the severity of illness and for detection of complications.
Restriction of fluid intake and provision of a high carbonate, low protein diet are desirable in subjects with renal involvement. Headache and muscular pains are treated with analgesic agents, and fever is managed with antipyretic agents. Intravenous injection of diazepam is very effective in controlling convulsions. Role of appropriate fluid management strategy titrated to clinical manifestations, state of illness and presence or otherwise of renal involvement cannot be over-emphasized. Oliguria due to dehydration or hypotension should be corrected and urine output maintained through fluid supplementation and restitution of blood pressure. After hydration and correction of blood pressure, furosemide (with doses up to 1000 mg/day) may be used to ensure adequate diuresis. Severe and worsening renal failure is treated with dialysis. It is advisable to institute dialysis early, as soon as BUN level reaches 200 mg/dl. Peritoneal dialysis is preferred to haemodialysis, as it is technically simpler. Plasmapheresis with dialysis may be effective for serious case with disturbance of consciousness.
Myocarditis requires pertinent cardiological treatment. Management of bleeding and thrombocytopenia may require packed cell transfusion, or platelet transfusion, respectively. Some authorities believe in prudent use of steroids in subjects with severe manifestations. However, association of remarkable haemorrhage, and macroscopic and histological changes with steroid therapy in experimentally infected guinea pigs cast doubts over its use.
Leptospires are sensitive to a variety of antimicrobial agents, including penicillin, cephems, aminoglycosides, tetracyclines and macrolides. ,,,,,,,,,,,,,,,,,, Of these antimicrobial agents, penicillin and cephems have the lowest minimal inhibitory concentrations (MIC) against leptospires in vitro .,, The results of several studies have shown that penicillin kills leptospires in the logarithmic growth phase, but not in the stationary phase.,, The same is true of cephaloridine, cefazolin and erythromycin.,, Streptomycin has been shown to kill leptospires in both the logarithmic growth phase and the stationary phase.,, High concentrations of tetracycline were associated with a leptospirocidal effect, which could not be attained with low concentrations of the drug.,, Gentamicin, tobramycin and isepamicin showed reliable bactericidal effects on leptospires in both the logarithmic growth phase and the stationary phase. ,,
Several in vivo studies done in lower animals (experimental leptospirosis) have shown that streptomycin was more effective than others in completely removing leptospires from all tissues.,, Although, penicillin, cephems, tetracyclines and macrolides were also effective in experimental leptospirosis, small numbers of leptospires sometimes remained in the liver and kidney.,,,,,, Recently, Truccolo et al. evaluated the susceptibility of leptospies to selected antimicrobial agents (ampicillin, doxycycline and ofloxacin) in a hamster model. Their results demonstrated the ability of ampicillin at a high dose to clear leptospires from the host, except from kidneys and heart, where leptospires remained at day 6. Ofloxacin was unable to clear leptospires from blood or kidneys. With doxycycline, the clearance of leptospires occurred in 2 days in all the target organs studied, with the exception of liver, which required 3 days. The standard treatment for carrier animals has been chemotherapy by injection of streptomycin; it is an effective cure for excretion of leptospires by carriers., A single dose of streptomycin will usually remove the chronic renal carrier state caused by pomona or other serovars. ,,Streptomycin has also been effectively used for acutely ill domestic animals.,
Studies on chemotherapy of leptospirosis carried out as early as 1950s through 1990s in human beings indicated a role for streptomycin and other aminoglycosides.,, Short-term treatment with streptomycin exterminates leptospires. It has been also shown to be effective for chemoprophylaxis and is used to treat subjects who are likely to have been infected in laboratory accidents or other high-risk exposure, except in circumstances where it is contraindicated., Gentamicin, tobramycin and isepamicin may be effective as alternatives to streptomycin. ,,
[Figure 1] shows the clinical course of Weil's disease in a patient treated with streptomycin beginning on the first day after onset of the illness. In this patient, the fever dropped precipitously and the causative leptospires were removed. Although the patient recovered quickly, jaundice and haemorrhage appeared after the fever subsided.
Although, penicillin was effective for treating leptospirosis, the causative organism has sometimes been isolated from the blood of patients after treatment with penicillin in the febrile stage. [Figure 2] shows the clinical course of a patient with leptospirosis treated with penicillin and streptomycin in the early stage. The causative organism was isolated from the blood of the patient during the time of treatment with penicillin, and afterward the patient recovered quickly, with streptomycin treatment. Recently, a sequential therapy of penicillin and doxycycline on a case of severe leptospirosis was reported. In this case, the patient progressed to pancytopenia despite initial penicillin therapy. The patient needed a second course of antimicrobial agent with doxycycline to improve his persistent symptoms and cytopenia.
Penicillin, cephems, tetracyclines and macrolides have been widely used in the treatment of human leptospirosis. However, when these antimicrobial agents are used for the treatment of leptospirosis, long-term therapy with large doses may be required from the early stage of the disease until the appearance of antibodies. [Table 1] shows the clinical application of principal drugs for treatment of leptospirosis.
The mortality due to leptospirosis varies from less than 1% to more than 20%. The mortality is dependent on many factors including the incriminated serovar with serovars icterohaemorrhagiae and copenhageni having the propensity to produce severe disease. The clinical spectrum of human leptospirosis ranges from mild anicteric illness to a severe illness characterized by multiple organ failure. The mild forms of leptospirosis may be much more common than the severe forms and most patients with the mild form tend to recover within 1-2 weeks. In addition to the serovar and severity of clinical spectrum, the types of clinical manifestations and complications also have a bearing on the fatality rate. Fatal outcome is mainly related to renal failure although other features such as hyperkalaemia, thrombocytopenia, cardiovascular failure with hypotension and arrhythmia, and respiratory failure with massive haemoptysis are known to contribute to the mortality rate. Neurological manifestations (e.g. disturbance of consciousness, delirium and stiffness of the neck) and digestive system symptoms (e.g. gastrointestinal bleeding, repeated nausea and vomiting, abdominal pain, meteorism and hiccups) are also associated with high mortality rate., Patient factors such as old age [Figure 3], nutritional status and presence of concomitant health problems are often associated with more severe clinical illness and increased mortality.
Most deaths occur between the 10th and 15th days of illness, although death can occur as early as the fifth day of illness in fulminant severe cases [Figure 4].
If the patient is not treated for the severe form within 2-3 days after the onset of illness, it may progress in severity and sometimes be fatal. Medical professionals, especially primary care physicians, who are primarily responsible for the diagnosis and treatment, need to know about the early symptoms and signs, and early clinical laboratory findings. The beginning of early pertinent antimicrobial therapy within 4-5 days after the onset of illness and proper supportive therapy and use of dialysis to treat renal failure have reduced the leptospirosis-related mortality.
|1||In : Faine S, editor. Guidelines for the control of leptospirosis. Geneva:World Health Organization; 1982. |
|2|| In : Kobayashi Y, editor. Leptosirosis. Proceedings of the Leptospirosis Conference 1990. Tokyo:University of Tokyo Press; 1991.|
|3|| In : Faine S, Adler B, Bolin C, Perolat P. Leptospira and Leptospirosis. 2nd edn. Melbourne:Med Sci; 1999.|
|4||Levett PN. Leptospirosis. Clin Microbiol Rev 2001;14:296-326.|
|5||Vinez JM. Leptospirosis. Curr Opin Infect Dis 2001;14:527-38.|
|6||Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, et al . Leptospirosis:a zoonotic disease of global importance. Lancet Infect Dis 2003;3:757-71.|
|7||International Leptospirosis Society (principal author Terpstra WJ). Human Leptospirosis:Guidance for diagnosis, surveillance and control. Geneva: World Health Organization; 2003. |
|8||Venkataraman KS, Nedunchelliyan S. Epidemiology of an outbreak of leptospirosis in man and dog. Comp Immunol Microbiol Dis 1992;15:243-7.|
|9||Sehgal SC, Murhekar MV, Sugunan AP. Outbreak of leptospirosis with pulmonary involvement in north Andaman. Indian J Med Res 1995;102:9-12.|
|10||Muthusethupathi MA, Shivakumar S, Suguna R, Jayakumar M, Vijayakumar R, Everard CO, et al . Leptospirosis in Madras a clinical and serological study. J Assoc Physic India 1995;43:456-8.|
|11||Kuriakose M, Eapen CK, Paul R. Leptospirosis in Kolenchery, Kerala, India;eidemiology, prevalent local serogroups and serovars and a new serovar. Eur J Epidemiol 1997;13:691-7.|
|12||Sehgal SC, Sugunan AP, Vijayachari P. Outbreak of leptospirosis after the cyclone in Orissa. Natl Med J India 2002;15:22-3.|
|13||Clerke AM, Leuva AC, Joshi C, Trivedi SV. Clinical profile of leptospirosis in South Gujarat. J Postgrad Med 2002;48:117-8.|
|14||Karande S, Kulkarni H, Kulkarni M, De A, Varaiya A. Leptospirosis in children in Mumbai slums. Indian J Pediatr 2002;69:855-8.|
|15||Natarajaseenivasan K, Boopalan M, Selvanayaki K, Suresh SR, Ratnam S. Leptospirosis among rice mill workers of Salem, South India. Jpn J Infect Dis 2002;55:170-3.|
|16||Bharadwaj R, Bal AM, Joshi SA, Kagal A, Pol SS, Garad G, et al . An urban outbreak of leptospirosis in Mumbai, India. Jpn J Infect Dis 2002;55:194-6.|
|17||Karande S, Bhatt M, Kelkar A, Kulkarni M, De A, Varaiya A. An observational study to detect leptospirosis in Mumbai, India, 2000. Arch Dis Child 2003;88:1070-5.|
|18||Sethi S, Sood A, Pooja, Sharma S, Sengupta C, Sharma M. Leptospirosis in northern India:a clinical and serological study. Southeast Asian J Trop Med Pub Health 2003;34:822-5.|
|19||Basu D, Sarkar P, Chakraborty N, Chanda PR, Biswas S, Bera AB, et al. Leptospirosis and Weil's disease in eastern India. J Indian Med Assoc 2003;101:532-6.|
|20||Ramakrishnan R, Patel MS, Gupte MD, Manickam P, Venkataraghavan S. An institutional outbreak of leptospirosis in Chennai, South India. J Commun Dis 2003;35:1-8.|
|21||Vijayachari P, Ahmed N, Sugunan AP, Ghousunnissa S, Rao KR, Hasnain SE, et al . Use of fluorescent amplified fragment length polymorphism for molecular epidemiology of leptospirosis in India. J Clin Microbiol 2004;42:3575-80.|
|22||Jena AB, Mohanty KC, Devadasan N. An outbreak of leptospirosis in Orissa, India:the importance of surveillance. Trop Med Int Health 2004;9:1016-21.|
|23||Pappachan MJ, Mathew S, Aravindan KP, Khader A, Bharghaven PV, Kareem MM, et al . Risk factors for mortality in patients with leptospirosis during an epidemic in northern Kerala. Natl Med J India 2004;17:240-2.|
|24||Misao T, Kobayashi Y, Kuwashima K, Yano T. Statistical observation on leptospirosis icterohaemorrhagica and canicola fever in the First Medical Clinic of Kyushu University Hospital for recent 16 years (in Japanese). Jpn J Clin Exp Med 1957;34:856-66. |
|25||Kobayashi Y. Clinical observation and treatment of leptospirosis. J Infect Chemother 2001;7:59-68.|
|26||Inada R, Ido Y, Kaneko R, Hoki R, Ito H, Wani H. Mitteilung über die Aetiologie, Immunitδt, Prophylaxis und Serumbehandlung der Weilschen Krankheit (Spirochaetosis icterohaemorrhagica Inada). Fukuoka:Mitteilungen aus der Medizinischen Fakultδt der Kaiserlichen Universitδt Kyushu, Fukuoka, Japan 1917;3:1-143. |
|27||Sanai T, Motomura K, Fujio N, Kumagai H, Hirakata H, Okuda S, et al . An urgent case of Weil's disease with fulminant renal failure and unconsciousness (In Japanese). Jpn J Clin Exp Med 1988;65:3853-6.|
|28||Aso M. The effects of antihistamic drug, rutin and cortisone on hemorrhage of leptospirosis icterohaemorrhagica (In Japanese). Fukuoka Med Acta 1955;46:188-201. |
|29||Misao T, Yamada H, Hiroyoshi S, Katsuta K, Nishihara Y, Tanaka H, et al . Chemothrapy of leptospirosis icterohaemorrhagica. 1. Basic experiments (in Japanese). Jpn J Clin Exp Med 1950;27:822-8.|
|30||Misao T, Yamada H, Hiroyoshi S, Katsuta K, Nishihara Y, Tanaka H, et al . Chemotherapy of leptospirosis icterohaemorrhagica. 2. Clinical application of penicillin and streptomycin (in Japanese). Jpn J Clin Exp Med 1951;28:424-31.|
|31||Misao T, Yamada H, Hiroyoshi Y, Katsuta K, Nishihara Y, Nagai S, et al . Chemotherapy of leptospirosis icterohaemorrhagica. 3.1. Experimental therapy of guinea pigs infected with Leptosira icterohaemorragiae using aureomycin and chloromycetin (in Japanese). Jpn J Clin Exp Med 1952;29:405-11.|
|32||Misao T, Yamada H, Hiroyoshi S, Katsuta K, Nishihara Y, Nagai S, et al . Chemotherapy of leptospirosis icterohaemorrhagica. Therapeutic effects of aureomycin on infected guinea pigs and patients with Leptospira icterohaemorrhagiae (in Japanese). Nippon Rinsho (Jpn J Clin Med) 1952;10:141-7.|
|33||Misao T, Hiroyoshi S, Katsuta K, Nishihara Y, Kuwashima K, Kobayashi Y. Terramycin therapy of leptospirosis icterohaemorrhagica (in Japanese). Jpn Med J 1952;1455:843-5.|
|34||Nishihara Y. An experimental study on the working mechanism of penicillin and streptomycin against Leptospira icterohaemorrhagiae (in Japanese). Fukuoka Acta Med 1952;43:935-51.|
|35||Misao T, Yamada H, Hiroyoshi S, Katsuta K, Nishihara Y, Nagai S, et al . Chemotherapy of leptospirosis icterohaemorrhagica. 3.2. Experimental therapy of hamsters infected with Leptospira icterohaemorrhagiae using Terramycin (in Japanese). Jpn J Clin Exp Med 1953;30:408-10.|
|36||Misao T, Yamada H, Hiroyoshi S, Katsuta K, Nishihara Y, Nagai S, et al . Chemotherapy of leptospirosis icterohaemorrhagica. Mode of action of various antibiotics against Leptospira icterohaemorrhagiae (in Japanese). Jpn J Clin Exp Med 1953;30:515-21.|
|37||Misao T, Hiroyoshi S, Katsuta K, Nishihara Y, Kuwashima K, Kobayashi Y. Ilotycin therapy. 2. Studies on the anti-leptospiral action of Ilotycin (in Japanese). J Jpn Soc Intern Med 1953;42:708-10.|
|38||Misao T, Hiroyoshi S, Katsuta K, Nishihara Y, Kuwashima K, Kobayashi Y. Therapeutic effects of Ilotycin on hamsters infected with Leptospira icterohaemorrhagiae (In Japanese). J Jpn Soc Intern Med 1954;42:880-3.|
|39||Kuwashima K. The influence of various antibiotics on Leptospira itcerohaemorrhagiae. II. Studies on the resistance of leptospira against antibiotics and the anti-leptospira action of tetracycline (in Japanese). Nisshin Igaku (Jpn J Med Prog) 1955;42:296-302.|
|40||Misao T, Kuwashima K, Kobayashi Y. Ilotycin therapy of leptospirosis (in Japanese). Saishin Igaku (Latest J Med Prog) 1955;10:1319-23.|
|41||Misao T, Hiroyoshi S, Katsuta K, Nishihara Y, Kuwashima K, Kobayashi Y. Antibiotics therapy of leptospirosis. 1. Basic section (in Japanese). Rinsho no Nippon (Clinics) 1955;1:199-207.|
|42||Misao T, Hiroyoshi S, Katsuta K, Nishihara Y, Kuwashima K, Kobayashi Y. Antibiotics therapy of leptospirosis. 2. Clinical section (in Japanese). Rinsho no Nippon (Clinics) 1955;1:274-85.|
|43||Kobayashi Y, Tachibana N. Chemotherapy of leptospirosis. Effects of leucomycin, Kanamycin, neomycin and novobiocin (in Japanese). J Jpn Assoc Infect Dis 1963;37:302.|
|44||Kobayashi Y, Ichiki T. Chemotherapy of leptospirosis. Effect of cephaloridine (in Japanese). J Jpn Assoc Infect Dis 1966;39:411.|
|45||Kobayashi Y, Tachibana N, Ichiki T, Kusaba T, Matsumoto I. Chemotherapy of leptospirosis. Effects of aminodeoxykanamycin, vistamycin and gentamicin (in Japanese). Media Circle 1971;16:335-40.|
|46||Kobayashi Y, Oyama T, Ninomiya T. Chemotherapy of leptospirosis. Effects of tobramycin, debekacin and amikacin on the leptospira (in Japanese). J Jpn Assoc Infect Dis 1984;58:197-202.|
|47||Kobayashi Y, Sada E, Tamai T, Shinozaki F. Activities of isepamicin and imipenem against leptospira. In : Kobayashi Y, editor. Leptospirosis. Proceedings of the Leptospirosis Research Conference 1990. Tokyo:University of Tokyo Press; 1991. p. 202-12. |
|48||Truccolo J, Charavay F, Merlen F, Perolat P. Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob Agents Chemother 2002;46:848-53.|
|49||Doherty P. Streptomycin treatment of bovine carriers of Leptospira pomona . Aust Vet J 1967;43:138-9.|
|50||Gerritsen MJ, Koopmans MJ, Olyhoek T. Effect of streptomycin treatment on the shedding of and the serologic responses to Leptospira interrogans serovar hardjo subtype hardjobovis in experimentally infected cows. Vet Microbiol 1993;38:129-35.|
|51||Gerritsen MJ, Koopmans MJ, Dekker TC, De Jong MC, Moerman A, Olyhoek T. Effective treatment with dihydrostreptomycin of naturally infected cows shedding Leptospira interrogans serovar hardjo subtype hardjobovis. Am J Vet Res 1994;55:339-43.|
|52||Bee PC, Chow SK, Tan LH. A cases of severe leptospirosis with pancytopaenia. Med J Malaysia 2003;58:777-9.|
|53||World Health Organization. Leptospirosis worldwide. Wkly Epidemiol Rec 1999;74:237-42.|